Our Immune Pan-antigen Cytotoxic Therapy (ImPACT®) platform is a cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate T-cells.

ImPACT® reprograms a live, genetically modified cancer cell line to continually secrete the heat-shock protein, gp96. Once the cell line is injected into the body along with a checkpoint inhibitor, they are bound to the cell’s own mutated antigens bound to gp96.

ImPACT® Technology

Learn how ImPact Technology works


The Immune System’s Swiss Army Knife


Our T-cell stimulating platform